MSTN and chronic kidney disease: In summary, we demonstrated in a slow progressing, naturally occurring model of CKD in animals with severe kidney disease there is enhanced activation of skeletal muscle stem cells, increased myostatin expression and downstream activation of the atrogenes, Atrogin-1 and MuRF1.